Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1996 Sep;74(5):796–801. doi: 10.1038/bjc.1996.438

Inflammatory infiltrate in invasive lobular and ductal carcinoma of the breast.

A H Lee 1, L C Happerfield 1, R R Millis 1, L G Bobrow 1
PMCID: PMC2074701  PMID: 8795584

Abstract

The significance of inflammation in carcinoma of the breast is controversial. Little attention has been paid to different patterns of inflammation or inflammation associated with different histological types of carcinoma. We have looked at the pattern of inflammation in 123 invasive mammary carcinomas (including 46 lobular), and characterised the inflammatory cells with immunohistochemistry in 21. We found different patterns of inflammation in ductal and lobular carcinoma. Diffuse inflammation was seen more in ductal carcinoma, particularly of high grade, and was predominantly composed of macrophages and T cells. It was associated with necrosis, but the correlation was weak, suggesting that other factors are important. Perilobular inflammation was seen most frequently in lobular and high-grade ductal carcinomas, particularly at the tumour edge. Perivascular inflammation was also largely at the tumour edge, but was not more common in any tumour type. In contrast to the diffuse inflammation, the perivascular and perilobular inflammation was composed of T and B cells. Normal lobules at the tumour edge showed consistent expression of HLA-DR, whereas lobules away from the tumour were negative. A combination of perilobular and perivascular inflammation composed of B and T cells with epithelial expression of HLA-DR mimicking lymphocytic lobulitis was seen more frequently in lobular than ductal carcinoma.

Full text

PDF
796

Images in this article

798Figure 1
on p.798
799Figure 2
on p.799
799Figure 3
on p.799

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aaltomaa S., Lipponen P., Eskelinen M., Kosma V. M., Marin S., Alhava E., Syrjänen K. Lymphocyte infiltrates as a prognostic variable in female breast cancer. Eur J Cancer. 1992;28A(4-5):859–864. doi: 10.1016/0959-8049(92)90134-n. [DOI] [PubMed] [Google Scholar]
  2. Alderson M. R., Hamlin I., Staunton M. D. The relative significance of prognostic factors in breast carcinoma. Br J Cancer. 1971 Dec;25(4):646–656. doi: 10.1038/bjc.1971.80. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. BLACK M. M., SPEER F. D. Periductal lymphoid infiltrations in mammary tissue. AMA Arch Pathol. 1955 Oct;60(4):457–461. [PubMed] [Google Scholar]
  4. Balch C. M., Riley L. B., Bae Y. J., Salmeron M. A., Platsoucas C. D., von Eschenbach A., Itoh K. Patterns of human tumor-infiltrating lymphocytes in 120 human cancers. Arch Surg. 1990 Feb;125(2):200–205. doi: 10.1001/archsurg.1990.01410140078012. [DOI] [PubMed] [Google Scholar]
  5. Bhan A. K., DesMarais C. L. Immunohistologic characterization of major histocompatibility antigens and inflammatory cellular infiltrate in human breast cancer. J Natl Cancer Inst. 1983 Sep;71(3):507–516. [PubMed] [Google Scholar]
  6. Black M. M., Barclay T. H., Hankey B. F. Prognosis in breast cancer utilizing histologic characteristics of the primary tumor. Cancer. 1975 Dec;36(6):2048–2055. doi: 10.1002/cncr.2820360919. [DOI] [PubMed] [Google Scholar]
  7. Bártek J., Petrek M., Vojtesek B., Bártková J., Kovarík J., Rejthar A. HLA-DR antigens on differentiating human mammary gland epithelium and breast tumours. Br J Cancer. 1987 Dec;56(6):727–733. doi: 10.1038/bjc.1987.278. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Chetty R., Butler A. E. Lymphocytic mastopathy associated with infiltrating lobular breast carcinoma. J Clin Pathol. 1993 Apr;46(4):376–377. doi: 10.1136/jcp.46.4.376. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Dvorak H. F., Dickersin G. R., Dvorak A. M., Manseau E. J., Pyne K. Human breast carcinoma: fibrin deposits and desmoplasia. Inflammatory cell type and distribution. Microvasculature and infarction. J Natl Cancer Inst. 1981 Aug;67(2):335–345. [PubMed] [Google Scholar]
  10. Elston C. W., Ellis I. O. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 1991 Nov;19(5):403–410. doi: 10.1111/j.1365-2559.1991.tb00229.x. [DOI] [PubMed] [Google Scholar]
  11. Elston C. W., Gresham G. A., Rao G. S., Zebro T., Haybittle J. L., Houghton J., Kearney G. The cancer research campaign (King's/Cambridge trial for early breast cancer: clinico-pathological aspects. Br J Cancer. 1982 May;45(5):655–669. doi: 10.1038/bjc.1982.106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Fisher E. R., Gregorio R. M., Fisher B., Redmond C., Vellios F., Sommers S. C. The pathology of invasive breast cancer. A syllabus derived from findings of the National Surgical Adjuvant Breast Project (protocol no. 4). Cancer. 1975 Jul;36(1):1–85. doi: 10.1002/1097-0142(197507)36:1<1::aid-cncr2820360102>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
  13. Giorno R. Mononuclear cells in malignant and benign human breast tissue. Arch Pathol Lab Med. 1983 Aug;107(8):415–417. [PubMed] [Google Scholar]
  14. Göttlinger H. G., Rieber P., Gokel J. M., Lohe K. J., Riethmüller G. Infiltrating mononuclear cells in human breast carcinoma: predominance of T4+ monocytic cells in the tumor stroma. Int J Cancer. 1985 Feb 15;35(2):199–205. doi: 10.1002/ijc.2910350210. [DOI] [PubMed] [Google Scholar]
  15. Hagemeier H. H., Vollmer E., Goerdt S., Schulze-Osthoff K., Sorg C. A monoclonal antibody reacting with endothelial cells of budding vessels in tumors and inflammatory tissues, and non-reactive with normal adult tissues. Int J Cancer. 1986 Oct 15;38(4):481–488. doi: 10.1002/ijc.2910380405. [DOI] [PubMed] [Google Scholar]
  16. Horny H. P., Horst H. A. Lymphoreticular infiltrates in invasive ductal breast cancer. A histological and immunohistological study. Virchows Arch A Pathol Anat Histopathol. 1986;409(2):275–286. doi: 10.1007/BF00708334. [DOI] [PubMed] [Google Scholar]
  17. Hurlimann J., Saraga P. Mononuclear cells infiltrating human mammary carcinomas: immunohistochemical analysis with monoclonal antibodies. Int J Cancer. 1985 Jun 15;35(6):753–762. doi: 10.1002/ijc.2910350610. [DOI] [PubMed] [Google Scholar]
  18. Kurtz J. M., Jacquemier J., Amalric R., Brandone H., Ayme Y., Hans D., Bressac C., Spitalier J. M. Why are local recurrences after breast-conserving therapy more frequent in younger patients? J Clin Oncol. 1990 Apr;8(4):591–598. doi: 10.1200/JCO.1990.8.4.591. [DOI] [PubMed] [Google Scholar]
  19. Lammie G. A., Bobrow L. G., Staunton M. D., Levison D. A., Page G., Millis R. R. Sclerosing lymphocytic lobulitis of the breast--evidence for an autoimmune pathogenesis. Histopathology. 1991 Jul;19(1):13–20. doi: 10.1111/j.1365-2559.1991.tb00889.x. [DOI] [PubMed] [Google Scholar]
  20. Lampejo O. T., Barnes D. M., Smith P., Millis R. R. Evaluation of infiltrating ductal carcinomas with a DCIS component: correlation of the histologic type of the in situ component with grade of the infiltrating component. Semin Diagn Pathol. 1994 Aug;11(3):215–222. [PubMed] [Google Scholar]
  21. Lauder I., Aherne W., Stewart J., Sainsbury R. Macrophage infiltration of breast tumours: a prospective study. J Clin Pathol. 1977 Jun;30(6):563–568. doi: 10.1136/jcp.30.6.563. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Lee A. H., Millis R. R., Bobrow L. G. Lymphocytic lobulitis and carcinoma of the breast. Histopathology. 1996 Jan;28(1):94–95. [PubMed] [Google Scholar]
  23. Lucin K., Iternicka Z., Jonjić N. Prognostic significance of T-cell infiltrates, expression of beta 2-microglobulin and HLA-DR antigens in breast carcinoma. Pathol Res Pract. 1994 Dec;190(12):1134–1140. doi: 10.1016/s0344-0338(11)80439-5. [DOI] [PubMed] [Google Scholar]
  24. Lwin K. Y., Zuccarini O., Sloane J. P., Beverley P. C. An immunohistological study of leukocyte localization in benign and malignant breast tissue. Int J Cancer. 1985 Oct 15;36(4):433–438. doi: 10.1002/ijc.2910360404. [DOI] [PubMed] [Google Scholar]
  25. Miescher S., Whiteside T. L., Carrel S., von Fliedner V. Functional properties of tumor-infiltrating and blood lymphocytes in patients with solid tumors: effects of tumor cells and their supernatants on proliferative responses of lymphocytes. J Immunol. 1986 Mar 1;136(5):1899–1907. [PubMed] [Google Scholar]
  26. Parl F. F., Dupont W. D. A retrospective cohort study of Histologic risk factors in breast cancer patients. Cancer. 1982 Dec 1;50(11):2410–2416. doi: 10.1002/1097-0142(19821201)50:11<2410::aid-cncr2820501128>3.0.co;2-5. [DOI] [PubMed] [Google Scholar]
  27. Ramachandra S., Machin L., Ashley S., Monaghan P., Gusterson B. A. Immunohistochemical distribution of c-erbB-2 in in situ breast carcinoma--a detailed morphological analysis. J Pathol. 1990 May;161(1):7–14. doi: 10.1002/path.1711610104. [DOI] [PubMed] [Google Scholar]
  28. Rilke F., Colnaghi M. I., Cascinelli N., Andreola S., Baldini M. T., Bufalino R., Della Porta G., Ménard S., Pierotti M. A., Testori A. Prognostic significance of HER-2/neu expression in breast cancer and its relationship to other prognostic factors. Int J Cancer. 1991 Aug 19;49(1):44–49. doi: 10.1002/ijc.2910490109. [DOI] [PubMed] [Google Scholar]
  29. Roses D. F., Bell D. A., Flotte T. J., Taylor R., Ratech H., Dubin N. Pathologic predictors of recurrence in stage 1 (TINOMO) breast cancer. Am J Clin Pathol. 1982 Dec;78(6):817–820. doi: 10.1093/ajcp/78.6.817. [DOI] [PubMed] [Google Scholar]
  30. Scholl S. M., Pallud C., Beuvon F., Hacene K., Stanley E. R., Rohrschneider L., Tang R., Pouillart P., Lidereau R. Anti-colony-stimulating factor-1 antibody staining in primary breast adenocarcinomas correlates with marked inflammatory cell infiltrates and prognosis. J Natl Cancer Inst. 1994 Jan 19;86(2):120–126. doi: 10.1093/jnci/86.2.120. [DOI] [PubMed] [Google Scholar]
  31. Schwartz I. S., Strauchen J. A. Lymphocytic mastopathy. An autoimmune disease of the breast? Am J Clin Pathol. 1990 Jun;93(6):725–730. doi: 10.1093/ajcp/93.6.725. [DOI] [PubMed] [Google Scholar]
  32. Syrjänen K. J., Hjelt L. H. Tumor-host interrelationships in carcinoma of the female breast. Surg Gynecol Obstet. 1978 Jul;147(1):43–48. [PubMed] [Google Scholar]
  33. Underwood J. C. Lymphoreticular infiltration in human tumours: prognostic and biological implications: a review. Br J Cancer. 1974 Dec;30(6):538–548. doi: 10.1038/bjc.1974.233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Wang J. M., Kumar S., Pye D., van Agthoven A. J., Krupinski J., Hunter R. D. A monoclonal antibody detects heterogeneity in vascular endothelium of tumours and normal tissues. Int J Cancer. 1993 May 28;54(3):363–370. doi: 10.1002/ijc.2910540303. [DOI] [PubMed] [Google Scholar]
  35. Zuk J. A., Walker R. A. Immunohistochemical analysis of HLA antigens and mononuclear infiltrates of benign and malignant breast. J Pathol. 1987 Aug;152(4):275–285. doi: 10.1002/path.1711520406. [DOI] [PubMed] [Google Scholar]
  36. van Ravenswaay Claasen H. H., Kluin P. M., Fleuren G. J. Tumor infiltrating cells in human cancer. On the possible role of CD16+ macrophages in antitumor cytotoxicity. Lab Invest. 1992 Aug;67(2):166–174. [PubMed] [Google Scholar]
  37. von Kleist S., Berling J., Bohle W., Wittekind C. Immunohistological analysis of lymphocyte subpopulations infiltrating breast carcinomas and benign lesions. Int J Cancer. 1987 Jul 15;40(1):18–23. doi: 10.1002/ijc.2910400105. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES